When the Money Stops: What’s at Risk in Cancer Research

Every cancer breakthrough begins with a single step—funding. In this episode of All Things Cancer, NFCR CEO Dr. Sujuan Ba speaks with leading researchers about the funding crisis threatening cancer research across the U.S. and beyond. From early-stage, high-risk studies to game-changing therapies now approaching clinical trials, these conversations reveal what’s possible when bold science is backed by strong support—and what’s lost when it isn’t.Hear from:Dr. Aaron Hata (Mass General Hospital)Dr. Jessica Lin (Mass General Cancer Center)Dr. Wayne Marasco (Dana-Farber Cancer Institute)Dr. Susan Horwitz (Albert Einstein College of Medicine)Dr. Alfred Slanetz and Dr. Raju Kucherlapati (Harvard Medical School)Whether you're a donor, advocate, or simply passionate about progress, this episode makes one thing clear: cancer doesn't wait—and neither can we.